Pet Drug Reports

Months › 2024

Month received

May 2024: adverse event reports received

7,698 reports in the openFDA release of 28 Sep 2026

7,698reports received
6,258same month a year earlier+23%
5,999monthly average, preceding 12 months
72%concern dogscats 16.6%

FDA's database holds 7,698 adverse event reports received in May 2024, against 6,258 in the same month a year earlier and a monthly average of 5,999 over the preceding 12 months.

72% of the month's reports concern dogs, 16.6% cats and 1% horses; the rest concern other species, exposed people, or give no species.

By active ingredient, the drugs named most often were pyrantel pamoate + sarolaner (1,117), bedinvetmab (846) and fluralaner (732), and the terms listed most often were vomiting (967), lethargy (624) and diarrhoea (483). Report volume has a seasonal shape, with more reports in the warmer months when parasite products are in heavier use.

The months around it

03,8497,698Nov 2022: 4,760Dec 2022: 3,925Jan 2023: 4,8162023Feb 2023: 4,413Mar 2023: 4,650Apr 2023: 5,288May 2023: 6,258Jun 2023: 6,148Jul 2023: 5,633Aug 2023: 6,367Sep 2023: 5,074Oct 2023: 6,154Nov 2023: 5,744Dec 2023: 4,825Jan 2024: 5,7842024Feb 2024: 6,098Mar 2024: 6,461Apr 2024: 7,444May 2024: 7,698Jun 2024: 7,392Jul 2024: 7,244Aug 2024: 7,460Sep 2024: 7,078Oct 2024: 7,101Nov 2024: 5,748

← Apr 2024Jun 2024 →

Drugs named most often, by active ingredient

Active ingredients recorded for the drugReportsShare of the month's reports
Pyrantel Pamoate + Sarolaner1,11714.5%
Bedinvetmab84611%
Fluralaner7329.5%
Ivermectin + Pyrantel Pamoate5727.4%
Afoxolaner4806.2%
Moxidectin3995.2%
Afoxolaner + Moxidectin + Pyrantel Pamoate3484.5%
Milbemycin Oxime + Praziquantel2933.8%
Frunevetmab2403.1%
Oclacitinib2122.8%
Gabapentin2022.6%
Nitenpyram1782.3%
Carprofen1652.1%
Velagliflozin1652.1%
Lotilaner1642.1%

Ordered by report count, which follows how widely each drug was in use. FDA states that these data cannot be used to estimate risk or to compare one product with another. Brand and manufacturer names are masked by FDA in these records.

Signs listed most often

  1. Vomiting12.6%967
  2. Lethargy[unusually tired or inactive]8.1%624
  3. Diarrhoea[diarrhea]6.3%483
  4. Lack of efficacy (ectoparasite) - flea[the product did not have the expected effect: fleas]6.1%468
  5. Lack of efficacy (endoparasite) - heartworm[the product did not have the expected effect: heartworm]5.5%426
  6. Lack of efficacy (endoparasite) - hookworm[the product did not have the expected effect: hookworms]4.8%372
  7. Seizure NOS[seizure, type not specified]4.3%332
  8. Lack of efficacy - NOS[the product did not have the expected effect]4.3%330
  9. Lack of efficacy (bacteria) - Borrelia[the product did not have the expected effect: Borrelia (Lyme disease bacteria)]4.2%327
  10. Death3.1%242
  11. Not eating3.1%241
  12. Death by euthanasia[the animal was euthanized]3%229
  13. Lack of efficacy (ectoparasite) - tick NOS[the product did not have the expected effect: ticks]2.9%226
  14. Emesis (multiple)[vomiting more than once]2.8%218
  15. Lack of efficacy (endoparasite) - roundworm NOS[the product did not have the expected effect: roundworms]2.5%195

Single ingredients, pooled

Sarolaner18.1%1,392
Moxidectin11.7%902
Afoxolaner10.5%806
Fluralaner10.5%805
Ivermectin7.8%604
Selamectin2.7%207

Species

Dog72%5,543
Cat16.6%1,280
Horse1%75
Other or not given10.4%800

Questions about May 2024

How many animal drug adverse event reports did FDA receive in May 2024?

7,698 reports are in the openFDA release of 28 Sep 2026. The same month a year earlier has 6,258.

Which drugs were named most often?

By active ingredient: pyrantel pamoate + sarolaner (1,117), bedinvetmab (846), fluralaner (732), ivermectin + pyrantel pamoate (572) and afoxolaner (480). Brands are masked in the public data.

Which signs were listed most often?

vomiting (967), lethargy (624), diarrhoea (483), lack of efficacy (ectoparasite) - flea (468) and lack of efficacy (endoparasite) - heartworm (426).

Can the count for a month still change?

Yes. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. Older months change little.

Does a busy month mean something went wrong that month?

Not by itself. The date is when FDA received the report, not when the event happened, and volume follows season, product launches and publicity. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources."

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 1 Oct 2026. The month is the date FDA first received the report, not the date of the event. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.